Basic Materials [ 7/11 ] | Specialty Chemicals [ 88/157 ]
US | NASDAQ | Stock
| Reported Date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Mar 15, 23 | -0.50
Decreased by
-516.67%
|
-0.27
Decreased by
-315.50%
|
| Nov 8, 22 | -0.44
Decreased by
-300.00%
|
-0.21
Decreased by
-521.54%
|
| Aug 9, 22 | -0.34
Decreased by
-780.00%
|
-0.26
Decreased by
-118.34%
|
| May 10, 22 | -0.37
Increased by
+65.74%
|
-0.30
Decreased by
-77.78%
|
| Mar 1, 22 | 0.12
Increased by
+127.27%
|
-0.20
Increased by
+800.00%
|
| Nov 8, 21 | -0.11
Increased by
+73.17%
|
-0.15
Increased by
+177.78%
|
| Aug 5, 21 | 0.05
Increased by
+108.93%
|
-0.13
Increased by
+1.07 K%
|
| May 6, 21 | -1.08
Decreased by
-92.86%
|
-0.02
Decreased by
-265.00 K%
|
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 22 | 71.13 M
Increased by
+48.60%
|
-161.40 M
Decreased by
-389.91%
|
Decreased by
-226.90%
Decreased by
-229.68%
|
| Jun 30, 22 | 65.21 M
Increased by
+24.64%
|
-110.01 M
Decreased by
-815.25%
|
Decreased by
-168.71%
Decreased by
-673.85%
|
| Mar 31, 22 | 57.71 M
Decreased by
-67.37%
|
-107.31 M
Increased by
+63.16%
|
Decreased by
-185.94%
Decreased by
-12.91%
|
| Dec 31, 21 | 64.78 M
Decreased by
-18.77%
|
37.84 M
Increased by
+134.52%
|
Increased by
+58.42%
Increased by
+142.50%
|
| Sep 30, 21 | 47.87 M
Increased by
+39.72%
|
-32.94 M
Decreased by
-42.27%
|
Decreased by
-68.83%
Decreased by
-1.82%
|
| Jun 30, 21 | 52.32 M
Increased by
+74.36%
|
15.38 M
Increased by
+113.93%
|
Increased by
+29.40%
Increased by
+107.99%
|
| Mar 31, 21 | 176.86 M
Increased by
+507.14%
|
-291.25 M
Decreased by
-231.55%
|
Decreased by
-164.68%
Increased by
+45.39%
|
| Dec 31, 20 | 79.74 M
Increased by
+96.72%
|
-109.62 M
Decreased by
-38.98%
|
Decreased by
-137.46%
Increased by
+29.35%
|
| Rank | ETF | Shares | Market Value | Weight % in ETF |
|---|
Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty, and flavors and fragrance markets in Europe, North America, Asia, and South America. The company manufactures and sells clean beauty, personal care, and health and wellness consumer products, as well as ingredients to the flavor and fragrance, nutrition, food and beverage, and clean beauty and personal care end markets. It offers its products under the Biossance, Pipette, Purecane, Terasana, Costa Brazil, OLIKA, Rose Inc., and JVN brand names. The company has a collaboration agreement with the Infectious Disease Research Institute for the development of a COVID-19 vaccine. The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc. in June 2010. Amyris, Inc. was incorporated in 2003 and is headquartered in Emeryville, California.